Sun Pharma chief, Dr. Reddy's, Natco and more—FiercePharmaAsia by Angus Liu Friday, August 16, 2019 Sun's Shanghvi took a 99% pay cut last year. Dr. Reddy's copies of Copaxone and NuvaRing were rejected by the FDA. Natco eyes China amid hardship.
FDA knocks Emcure with warning letter after injectables recall by Kyle Blankenship Thursday, August 15, 2019 Emcure has had its share of run-ins with the FDA in the past over the sterility of its plants. Now, it can notch one more black mark on its belt.
Big Pharma in China, Pfizer Upjohn and more—FiercePharmaAsia by Angus Liu Friday, May 31, 2019 Big Pharma's older drugs face pricing pressure in China; Pfizer moves Upjohn HQ to Shanghai; Hansoh Pharma eyes $1 billion Hong Kong IPO.
Emcure schizophrenia drug recalled after contamination spotted by Eric Palmer Tuesday, May 28, 2019 Two injected drugs manufactured by an Indian company with a history of sterility problems are being recalled because of contamination concerns.
